Hutch News
Results per Page:
One step closer to personalized oncology for chemo-resistant ovarian cancer
From the Paulovich Lab, Translational Science and Therapeutics Division
Big-picture approach helps identify experimental diagnostic to personalize ovarian cancer treatment
Team uses large-scale proteogenomic changes to identify which patients should look beyond standard treatment options
MYCN drives the development of chemoresistance in small cell lung cancer
From the MacPherson lab, Human Biology Division
Is it possible to prevent breast cancer metastasis?
Study reveals how blood vessels in the bone marrow protect dormant tumor cells, suggests a way to kill them in their sleep
More than hair: Cancer researcher with cancer writes about identity
A cancer researcher with cancer writes about family, identity and being outed by her own hair
Potential breakthrough in pancreatic cancer treatment
Sunil Hingorani-led study breaks unique tumor defense, extends survival in mice by 70 percent; initial human studies under way
Hutchinson Center scientists break through pancreas cancer treatment barrier
Research study reports extending survival in mice by 70 percent; initial studies in humans are under way
Kuni Scholar award paves way for breakthrough research
Medical scientist Maria Corinna Palanca-Wessels, working to defeat ovarian cancer, is among three Pacific Northwest scientists in the inaugural class of Kuni Scholars
Modified marrow cells may resist chemotherapy’s toxic effects
Hans-Peter Kiem and colleagues find chemo-resistant genes may enable safer, more effective treatment for brain cancer patients
Why pancreatic-cancer drugs can fail
Sunil Hingorani and an international team of investigators shed light on reasons patients are often resistant to gemcitabine treatment
Two Center researchers win Howard Hughes Medical Research Institute awards
Drs. Harmit Malik and Toshiyasu Taniguchi are among 50 scientists nationwide to win appointments as Early Career Scientists
Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
Mechanism of cisplatin resistance 'unlike any previously identified'
New use for a cell toxin found to inhibit survival proteins in cancer cells
Findings could lead to new drug to lower resistance to cancer therapies